Who am I?

Zhou (Joe) Lan is an associate director at Real-World Evidence Analytics on Sanofi’s HEVA Team. He earned his PhD in Statistics from North Carolina State University in 2019 and has since focused on real-world evidence studies examining treatment effectiveness, as well as biobank studies supporting R&D biomarker investigation, at Brigham and Women’s Hospital–Harvard Medical School. As both a lead investigator and collaborative team member in medical research, he has contributed to numerous studies with publications in prestigious journals including JAMIA Open, NEJM, JAHA, JAMA Network Open, Circulation, Neuro-Oncology, and Imaging Neuroscience. As trained biostatistician and data scientist, he has served as lead author on more than 15 publications in prominent journals such as Technometrics, Biometrics, Journal of the Royal Statistical Society: Series A, Data Science in Science.

Investigation Areas

• Biobank Analystics Large-scale imaging/digital-device/omics research using biobanks and population cohorts (e.g., Human Connectome Project, ABCD Study, Boston Scientific’s ALTITUDE database, and NCDR ICD Registry).
• Real World Evidence Analytics Epidemiological Real-world Studies and Outcomes Research: Analysis of EHRs, insurance claims, registry data for treatment effectiveness, safety evaluation, and patient trajectory modeling using advanced causal inference and survival methods.
• Clinical Trials Supporting late clinical studies using rigorous statistical methodology.

Therapeutic Areas

• Neuroscience for mathematical equations
• Cardiology for diagraming
• Oncology for plotting

Statistical Methodology

• Bayesian Inference and Methods for mathematical equations
• Nonparametric Modeling for diagraming
• Multivariate Modeling for plotting